UPDATED Apr 21, 2024
Companys with strong funding and high growth potential
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IPH | €2.11 | -6.6% | -22.0% | €170.6m | €6.27 | PS2.8x | E33.0% | n/a | Pharmaceuticals & Biotech | ||
GNFT | €3.16 | -2.5% | -3.8% | €157.1m | €9.38 | PS4.6x | E54.7% | n/a | Pharmaceuticals & Biotech | ||
DBV | €1.24 | -4.2% | -58.9% | €119.3m | €4.78 | PS8.1x | E53.3% | n/a | Pharmaceuticals & Biotech | ||
PHXM | €2.92 | -0.5% | -65.2% | €17.7m | €6.85 | PS13.4x | E144.6% | n/a | Pharmaceuticals & Biotech |